Advertisement

Larynx

  • Gregory D. Judy
  • Bhishamjit S. Chera
Chapter

Abstract

Early-stage glottic SCC carries a favorable prognosis with low rates of long-term complications when treated with RT. One particular advantage to using RT is improved preservation of voice quality compared to laryngectomy. Historically, small, daily fractions were used to treat these lesions; however, treatment has evolved to a more hypofractionated, shorter overall treatment course without sacrificing LC or increasing complications. This chapter summarizes the use of hypofractionated RT for the treatment of early-stage SCC of the glottic larynx.

Keywords

Laryngeal carcinoma Radiation therapy Hypofractionation 

References

  1. 1.
    Garden AS, Beadle BM, Morrison WH. Larynx and hypopharynx cancer. Clinical radiation oncology. 4th ed. Philadelphia, PA: Saunders/Elsevier. p. 649–72.Google Scholar
  2. 2.
    Treatment of early (stage I and II) head and neck cancer: The larynx. Accessed 22 July 2016.Google Scholar
  3. 3.
    Moon SH, Cho KH, Chung EJ, et al. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean radiation oncology group (KROG-0201) study. Radiother Oncol. 2014;110:98–103.CrossRefPubMedGoogle Scholar
  4. 4.
    Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64:77–82.CrossRefPubMedGoogle Scholar
  5. 5.
    Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:461–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;39:115–26.CrossRefPubMedGoogle Scholar
  7. 7.
    Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol. 2003;68:105–11.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Gregory D. Judy
    • 1
    • 2
  • Bhishamjit S. Chera
    • 1
    • 2
  1. 1.Department of Radiation OncologyUniversity of North Carolina School of MedicineChapel HillUSA
  2. 2.Lineberger Comprehensive Cancer CenterUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations